Career setbacks cited in S'pore survey of people seeking fertility help
Top workplace challenges cited were seeking approval for time off (34 per cent), career progression setbacks (31 per cent) and getting their colleagues' understanding (15 per cent).
These findings come from a sensing poll in June by non-profit initiative Fertility Support Singapore, which surveyed 504 of its members – 80 per cent women and 20 per cent men – who have faced fertility struggles.
The poll aims to shed light on the workplace experiences of those facing infertility, defined as an inability to conceive after 12 months of trying. Results were released on July 25 at an event hosted by Fertility Support Singapore to mark World IVF Day.
The demand for in-vitro fertilisation (IVF) treatment in Singapore has grown, with more couples delaying marriage and childbirth, and seeking medical help to have a baby.
Giving a speech at the event, Ms Indranee Rajah, Minister in the Prime Minister's Office, called for more companies to provide fertility benefits such as paid time off and training for managers, so that employees can pursue both personal and work commitments.
'You have the power to create workplaces where employees feel seen, heard and supported, and where talent feel cherished and stand ready to give their all in return to support your business needs. That is a win-win outcome,' she said.
Ms Indranee, who assists in overseeing the National Population and Talent Division, including the marriage and parenthood portfolio, said the Government has provided 75 per cent co-funding for eligible couples to receive assisted reproduction technology treatments for up to three fresh and three frozen cycles at public healthcare institutions.
Fertility Support Singapore was started in 2020 by a group of women facing infertility, to advocate for better support for individuals navigating challenges here.
On July 25, the group launched a Workplace Fertility Support Guide to help companies better support employees.
The guide provides practical tools such as an e-mail template for those going through fertility treatments to raise the matter to bosses, the typical IVF timeline and medical leave required, and tips on how to talk to colleagues undergoing treatment.
The guide can be found at https://fertilitysupport.sg/infertility-in-the-workplace/
To understand the barriers to fertility support in the workplace, Fertility Support Singapore partnered with market research firm Milieu Insight to conduct a study in March with 400 Singaporeans aged 25 to 55.
The survey found public awareness to be lacking, with 62 per cent not knowing what fertility support is. Some 77 per cent of respondents perceive a trade-off between work and pursuing such treatments.
Nearly 60 per cent of people would be interested in joining a new employer that offers fertility benefits, results showed.
Only 27 per cent said their companies provided some form of fertility benefits, such as flexible work hours to attend appointments, and paid or unpaid leave for treatment.
Ms Rosalyn Wee and her husband sought help from a fertility specialist after a year of trying to conceive.
The educational therapist and project lead, who underwent IVF, did not tell her boss as she felt fertility treatments were personal. 'It doesn't really occur to you how painful emotionally and physically discomfiting it is, until you actually go through it,' she said.
Her first embryo transfer ended in failure. The news came while she was in an important meeting. 'That really broke me,' she said. She decided to open up to her bosses, who offered both paid and unpaid leave for treatment.
After taking 10 weeks of no-pay leave for another IVF cycle, Ms Wee successfully conceived in August 2023.
Another mum, Mrs Rafidah Jalil, 39, had just been promoted and was managing a team at a bank when she decided to start a family at 31. Her first IVF cycle was successful.
At 34, she tried IVF again but felt more stress due to greater work responsibilities and a lower egg count. But her bosses were supportive, and she could work flexibly, which helped her through the process.
She is now a proud mum of a seven-year-old son and four-year-old boy-girl twins.
Global healthcare company Merck, which sponsored the Fertility Support Singapore study, offers a lifetime cap of €100,000 (S$150,234) for fertility treatments, including IVF, elective egg freezing and male infertility treatments. Employees can get 90 per cent of their eligible fertility expenses reimbursed by the company.
Ms Pixie Yee, general manager of Merck Healthcare Malaysia and Singapore, said the company has seen 79 claims amounting to $160,000 since the benefit was introduced in March 2024. Merck has 429 employees in Singapore.
Ms Yee said she hopes to create a safe space where employees feel comfortable to tell their bosses about their fertility journey, to avoid any misunderstandings. 'Most people, when they have a very supportive manager, they will share,' she added.
Source: The Straits Times © SPH Media Limited. Permission required for reproduction
Discover how to enjoy other premium articles here
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
2 days ago
- Fox News
Find your next beauty favorite on Amazon – new products from Estée Lauder to BareMinerals
Embrace the vibrant energy of summer with a refreshed beauty routine. Amazon is launching trending beauty products to enhance your natural glow. Discover fresh releases from brands like Estée Lauder, BareMinerals, Laneige and Milk Makeup, alongside everyday favorites from e.l.f. Cosmetics, NYX and Billie. Amazon is also featuring new arrivals from innovators like Olive & June, Uncommon Beauty, Thrive Causemetics and Wander Beauty. Find all of summer's trending beauty launches in one place — shop them now on Amazon. You can get your new beauty picks delivered overnight by signing up for a Prime membership. Original price: $12.99 This Billie AHA Deodorant in Tidal Rose scent uses a pH-adjusting multi-acid blend (including lactic, mandelic and salicylic acids) to fight odors. It is formulated without the addition of aluminum and baking soda, so it is suitable for sensitive skin. The EltaMD UV Skin Recovery Face Sunscreen with Zinc Oxide, SPF 50 is specifically designed to address sensitive skin, redness and barrier repair. Grab the viral Laneige lip sleeping mask in the new murumuru butter flavor. This beloved overnight treatment deeply hydrates and softens dry, flaky lips. Its rich, balm-like texture works while you sleep to create a protective moisture barrier. Bioderma Sensibio H2O Micellar Water is a staple in the beauty industry for its gentle, skin-respecting formula. It is nonetheless highly effective at lifting away makeup, dirt and impurities without the need for harsh rubbing or rinsing. Estée Lauder Advanced Night Repair face serum is a timeless favorite that delivers intense hydration to help rejuvenate the skin overnight, while also providing eight-hour antioxidant protection to defend the skin against environmental stressors. The ELEMIS pro-collagen cleansing balm facial cleanser and makeup remover begins as a solid balm that melts into a silky cleansing oil, dissolving makeup (even waterproof), daily pollutants and impurities from the skin. When water is added, it emulsifies into a hydrating milky lather that rinses clean without stripping the skin. Use Wander Beauty Baggage Claim Eye Masks to address common concerns like puffiness, dark circles, fine lines and dryness. The gold-foil masks are formulated with hydrating ingredients to help brighten, hydrate, soothe and de-puff the under-eye area. Original price: $48.99 TruSkin Vitamin C Facial Serum contains a stable and generally well-tolerated form of vitamin C, along with vitamin E and aloe vera. This brand is an Amazon favorite for brightening and improving skin tone. Original price: $17.99 Use the CeraVe Hydrating Facial Cleanser on normal to dry skin, including sensitive and eczema-prone skin. This cleanser helps to restore and maintain the skin's protective function, keeping moisture in and irritants out. The Milk Makeup Hydro Grip Primer, formulated with hyaluronic acid is a silicone-free gel primer that creates a grippy base to lock makeup in place for up to 12 hours. The formula uses blue agave extract to create a tacky surface on the skin, which prevents foundation and other face makeup from sliding, caking or fading. bareMinerals Original Loose Powder Foundation SPF 15 features a simple, clean ingredient list, making it suitable for a wide range of skin types, including sensitive skin. It is made with only five clean, vegan mineral ingredients. The foundation pigments and physical sunscreens providing SPF 15 protection. Try the e.l.f. Glow Reviver Melting Lip Balm for a hydrating, tinted lip balm that gives your lips a high-gloss shine and deep nourishment. It is formulated with a 10% blend of nourishing butters, including shea butter, mango butter and cocoa butter to moisturize and condition dry lips. Try the Olive & June super stick mani press-on nails when you are in a pinch and have no time for a manicure. These press-ons feature patented adhesive tabs for up to seven days of wear, eliminating the need for glue. The Uncommon Beauty Body Oil features a rich blend of oils like sunflower, coconut, seabuckthorn, jojoba, olive and more. This combination aims to replenish moisture, smooth and protect the skin and calm stressed or sensitive areas. For more deals, visit Try the Thrive Causemetics Infinity Waterproof Eyeliner Pencil if you are looking for a high-performance eyeliner that is waterproof and smudge-proof. This ultra-creamy pencil glides on effortlessly, with color that sets in roughly 30 to 60 seconds.


Business Wire
6 days ago
- Business Wire
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance imaging (MRI) system for the brain—the Swoop® system—today announced the enrollment of the first patients in the PRIME (Portable Rapid Imaging for Medical Emergencies) study. This study aims to evaluate the potential of AI-powered portable MRI technology to transform triage in the emergency department (ED) setting. "Given many EDs don't have ready access to MRI, this study could alter paradigms of advanced imaging access and utilization in the ED." The PRIME study at Yale School of Medicine builds on the ACTION PMR study, which demonstrated the utility of AI-powered portable MRI in the diagnosis and management of stroke patients in emergency department settings. Expanding the scope of patients studied, the PRIME study will include a broad and diverse set of patients presenting in an emergency department and assess the technology's potential effectiveness and efficiency as a triage tool for a wide range of brain-related emergency medical conditions. Unlike ACTION PMR, the PRIME study is being conducted using the recently released next-generation Swoop® system powered by Optive AI™ software. PRIME will be one of the first studies using the new software's advanced image quality that provides sharper anatomical detail, thus potentially enabling greater pathology detection. Hyperfine's portable MRI technology has established its value in healthcare institutions, providing high-quality brain imaging at the bedside for critically ill adult and pediatric patients. Timely access to MRI in emergency department settings is still a challenge for many hospitals. Prolonged patient boarding in EDs has been cited as the top priority for hospital leaders, as evidenced in the December 2024 article in Becker's Hospital Review 1. By removing the traditional barriers associated with access to conventional MRI scanners—such as wait times, shortage of dedicated MRI technologists, cost, and immobility—portable MR imaging enables faster, more efficient decision-making in emergency department settings. The PRIME study will enroll patients in a Level 1 emergency department, assessing a broad spectrum of emergency medical conditions. 'By evaluating the potential of portable MRI in this real-world setting, this study aims to determine if a portable MRI system can provide diagnostic imaging capabilities that can be quickly integrated into the ED workflow to improve patient care decisions in real time,' said Dr. Kevin Sheth, Professor of Neurology and Neurosurgery at the Yale School of Medicine and principal investigator for the PRIME study, who is working in close collaboration with his co-PI Dr. Adam De Havenon. 'Given many EDs don't have ready access to MRI, this study could alter paradigms of advanced imaging access and utilization in the ED,' said Dr. Charles Wira, Associate Professor of Emergency Medicine at Yale University. 'The Hyperfine portable MRI system could immediately provide ED clinicians and consulting physicians with critical imaging data at the point of care, helping them to make more informed, faster decisions when every second counts.' 'Hyperfine is thrilled to collaborate with Yale on this transformative project. The Yale team has worked with portable brain MRI since the technology's early days,' said Maria Sainz, President and CEO of Hyperfine. 'Through the PRIME study, they demonstrate a bold vision for how portable MRI can accelerate triage in emergency care. The next-generation Swoop® system, powered by Optive AI™ software, provides more clinically valuable image quality that we expect will drive greater adoption in the emergency setting and help address the widespread clinical and economic challenges of ED boarding.' Hyperfine is committed to advancing the role of portable MRI in emergency care of the brain, one of the sites of care where access to conventional MRI is challenging. The PRIME study represents a strategic initiative within the broader Hyperfine hospital market strategy to drive commercial growth, demonstrating how the placement of portable MRI systems in emergency departments can unlock timely diagnostic access and improve clinical workflows at the point of care. For more information about the Swoop® system, please visit For more information about the PRIME study, including enrollment details and eligibility criteria, please visit 1. ED boarding: 10 things to know. Becker's Hospital Review. About the Swoop® Portable MRI Systems The Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. About Hyperfine, Inc. Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Actual results of Hyperfine, Inc. (the 'Company') may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as 'expect,' 'estimate,' 'project,' 'budget,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'may,' 'will,' 'could,' 'should,' 'believes,' 'predicts,' 'potential,' 'continue,' and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's goals and commercial plans, the benefits of the Company's products and services, and the Company's future performance and its ability to implement its strategy. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the success, cost and timing of the Company's product development and commercialization activities, including the degree that the Swoop® system is accepted and used by healthcare professionals; the impact of COVID-19 on the Company's business; the inability to maintain the listing of the Company's Class A common stock on the Nasdaq; the Company's inability to grow and manage growth profitably and retain its key employees; changes in applicable laws or regulations; the inability of the Company to raise financing in the future; the inability of the Company to obtain and maintain regulatory clearance or approval for its products, and any related restrictions and limitations of any cleared or approved product; the inability of the Company to identify, in-license or acquire additional technology; the inability of the Company to maintain its existing or future license, manufacturing, supply and distribution agreements and to obtain adequate supply of its products; the inability of the Company to compete with other companies currently marketing or engaged in the development of products and services that the Company is currently marketing or developing; the size and growth potential of the markets for the Company's products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company's products and services and reimbursement for medical procedures conducted using the Company's products and services; the Company's estimates regarding expenses, revenue, capital requirements and needs for additional financing; the Company's financial performance; and other risks and uncertainties indicated from time to time in Company's filings with the Securities and Exchange Commission, including those under 'Risk Factors' therein. The Company cautions readers that the foregoing list of factors is not exclusive and that readers should not place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.


Business Wire
7 days ago
- Business Wire
Prime Healthcare Achieves National Recognition for Exemplary Social Responsibility by Lown Institute
ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare has been recognized as a national leader in hospital social responsibility, with 46 of its hospitals earning 'A' grades on the 2025-26 Lown Institute Hospitals Index. Among more than 3,500 hospitals evaluated nationwide, Prime hospitals stood out for their exceptional performance in health equity, patient outcomes and value of care—key measures that reflect a hospital's impact on the communities it serves. Recognized for health equity and patient outcomes, 46 Prime hospitals received top 'A' grades on the 2025-26 Lown Index, reflecting the system's commitment to socially responsible care. Share Eight Prime hospitals earned top ranks in their states across various domains, including health equity, patient safety and community impact: Saint Francis Hospital ranked No. 1 in the nation for Pay Equity and #1 in Illinois for Pay Equity Saint Mary of Nazareth Hospital ranked No. 1 in Illinois for Health Equity East Liverpool City Hospital ranked No. 1 in Ohio for Social Responsibility and Pay Equity Garden City Hospital ranked No. 1 in Michigan for Patient Safety Landmark Medical Center ranked No. 1 in Rhode Island for Health Equity, Inclusivity and Pay Equity North Vista Hospital ranked No. 1 in Nevada for Social Responsibility, Health Equity, Community Benefit, Inclusivity and Racial Inclusivity Providence Medical Center ranked No. 1 in Kansas for Social Responsibility Saint Clare's Denville ranked No. 1 in New Jersey for Avoiding Overuse The Lown Institute Hospitals Index is an independent national ranking that evaluates hospitals on more than 50 metrics across equity, value and outcomes—factors often overlooked in traditional hospital ratings. 'Hospitals are facing unprecedented political and financial challenges,' said Vikas Saini, MD, president of the Lown Institute. 'In this uncertain environment, it's more important than ever to support the socially responsible hospitals who are delivering high-quality care to all in their community.' Prime Healthcare continues to strengthen its mission to save and improve hospitals through measurable results. The system's strong showing across the Index reflects focused investments in care quality, physician leadership and a commitment to serving vulnerable and underserved populations. 'Social responsibility and health equity are not just goals—they are a reflection of our purpose as a healthcare organization,' said Sunny Bhatia, MD, President and Corporate Chief Medical Officer of Prime Healthcare. 'It is a profound responsibility and honor to care for our communities, and I commend our caregivers for the compassion, excellence and integrity they bring to every patient encounter.' Sixteen of the hospitals recognized this year are not-for-profit facilities supported by the Prime Healthcare Foundation, reinforcing the Foundation's mission to expand access and advance health equity in underserved communities. 'We are proud of the extraordinary physicians and staff at our Foundation hospitals who bring our mission to life each day,' said Kavitha Bhatia, MD, President and Chair of the Prime Healthcare Foundation. 'Their unwavering commitment to compassionate, high-quality care ensures that dignity, respect and equity remain central to every patient experience. This recognition is a testament to their leadership and dedication.' Four Prime Healthcare hospitals earned a spot on the prestigious Lown Institute Honor Roll, receiving straight 'A' grades across all measured categories, including Social Responsibility, Health Equity, Value of Care and Patient Outcomes: The Lown Hospitals Index for Social Responsibility is the only ranking to combine metrics of health equity and value of care alongside patient outcomes for more than 2,700 acute care and 800 critical access hospitals nationwide, offering a holistic view of hospitals as total community partners. In the sixth annual rankings, the 2025-26 Lown Index evaluates hospitals on over 50 measures including novel metrics such as community benefit, racial inclusivity, and avoidance of overuse. Data sources include Medicare fee-for-service and Medicare Advantage claims, CMS patient safety data and hospital cost reports, and IRS 990 forms, among others. Full methodology can be found on the Lown Index website. The full list of the 46 Prime Healthcare/Prime Healthcare Foundation 2025-26 Lown Institute Hospitals Index awardees is as follows: Centinela Hospital Medical Center, Inglewood, CA; Chino Valley Medical Center; Chino, CA; Coshocton Regional Medical Center, Coshocton, OH; Dallas Medical Center, Dallas, TX; Dallas Regional Medical Center, Mesquite, TX; Desert Valley Hospital, Victorville, CA; East Liverpool City Hospital, East Liverpool, OH; Encino Hospital Medical Center, Encino, CA; Garden City Hospital, Garden City, MI; Garden Grove Hospital Medical Center, Garden Grove, CA; Harlingen Medical Center, Harlingen, TX; Huntington Beach Hospital, Huntington Beach, CA; Knapp Medical Center, Weslaco, TX; La Palma Intercommunity Hospital, La Palma, CA; Lake Huron Medical Center, Port Huron, MI; Landmark Medical Center, Woonsocket, RI; Lehigh Regional Medical Center, Lehigh Acres, FL; Lower Bucks Hospital, Bristol, PA; Mercy Medical Center, Aurora, IL; Mission Regional Medical Center, Mission, TX; Monroe Hospital, Bloomington, IN; Montclair Hospital Medical Center, Montclair, CA; North Vista Hospital, North Las Vegas, NV; Paradise Valley Hospital, National City, CA; Providence Medical Center, Kansas City, KS; Resurrection Medical Center, Chicago, IL; Riverview Regional Medical Center, Gadsden AL; Roxborough Memorial Hospital, Philadelphia, PA; Saint Clare's Denville, Denville, NJ; Saint Francis Hospital, Evanston, IL; Saint Joseph Hospital, Elgin, IL; Saint Joseph Medical Center, Joliet, IL; Saint Mary of Nazareth Hospital, Chicago, IL; Saint Mary's Regional Medical Center, Reno, NV; Saint Michael's Medical Center, Newark, NJ; San Dimas Community Hospital, San Dimas, CA; Shasta Regional Medical Center, Redding, CA; Sherman Oaks Hospital, Sherman Oaks, CA; Southern Regional Medical Center, Riverdale, GA; St. Francis Medical Center, Lynwood, CA; St. Joseph Medical Center, Kansas City, MO; St. Mary's General Hospital, Passaic, NJ; St. Mary's Hospital, Kankakee, IL; St. Mary's Medical Center, Kansas City, MO; Suburban Community Hospital, Norristown, PA; West Anaheim Medical Center, Anaheim, CA. About Prime Healthcare and Prime Healthcare Foundation Prime Healthcare is an award-winning health system operating 51 hospitals and more than 360 outpatient locations in 14 states, providing over 2.5 million patient visits annually. It is one of the nation's leading health systems, with nearly 57,000 employees and physicians. Eighteen of the Prime Healthcare hospitals are members of the Prime Healthcare Foundation, a 501(c)(3) not-for-profit public charity. Based in Ontario, California, Prime Healthcare is nationally recognized for award-winning quality care and has been named a 10 Top and 15 Top Health System by Truven Health Analytics. Its hospitals have been named among the nation's '100 Top Hospitals' 72 times and is one of Healthgrades most awarded health systems in the nation for patient safety. To learn more, please visit